Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a leading provider of life science research and clinical diagnostics products, has announced the appointment of Jon DiVincenzo as President and Chief Operating Officer, starting September 9, 2024. DiVincenzo will succeed Andy Last, who is retiring.
Jon DiVincenzo is joining Bio-Rad Laboratories, Inc. as President and Chief Operating Officer, effective September 9, 2024, succeeding Andy Last, who is retiring. DiVincenzo comes from Labcorp Holdings Inc., where he was Executive Vice President and President of Central Laboratories and International, overseeing global operations and commercial leadership. His previous roles include President of the Environmental Health Division at PerkinElmer, CEO of Enzymatics, and various positions at EMD Millipore. He holds a B.S. in mechanical engineering from Northeastern University.
Norman Schwartz, Bio-Rad’s Chairman and CEO, expressed enthusiasm about DiVincenzo’s appointment, highlighting his extensive industry experience in operations, marketing, and product development, which will support Bio-Rad’s continued growth.
DiVincenzo shared his excitement about joining Bio-Rad and working with the team to advance the company’s long-term goals.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a global leader in life science research and clinical diagnostics. Headquartered in Hercules, California, Bio-Rad’s extensive network includes over 7,700 employees and $2.7 billion in revenues for 2023. The company provides innovative products to universities, research institutions, hospitals, and biopharmaceutical companies, aiming to advance science and improve lives.
